Jamie Holland
Family · Nashville, TNNPI 1841796091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,791 and has fallen 97.8% since, to $40 in 2024.
Across 148 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$403
- GSK$245
- AbbVie$229
- Amgen$188
- AstraZeneca$167
- Boehringer Ingelheim$120
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,34197%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $403 |
| GSK | 13 | $245 |
| AbbVie | 12 | $229 |
| Amgen | 13 | $188 |
| AstraZeneca | 12 | $167 |
| Boehringer Ingelheim | 7 | $120 |
| Astellas Pharma US Inc | 4 | $112 |
| Lilly USA, LLC | 6 | $92 |
| Merck | 6 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Johnson & Johnson | 5 | $77 |
| Abbott | 4 | $72 |
| Pfizer | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Sanofi Pasteur Inc. | 3 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| Bayer | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 3 | $40 |
| Dexcom, Inc. | 2 | $32 |
| Genentech USA, Inc. | 3 | $27 |
| Amarin Pharma, Inc. | 2 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Nevro Corp. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Eisai Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Biogen | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $11 |
How this compares
$2,406 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 16 | $268 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $190 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $177 |
| Azithromycin | 22 | $30 |
| Prednisone | 22 | $29 |
Paid to pharmacies, not to this prescriber.
Other family in Nashville
- Tamera ThoenerNashville$254K
- Jennifer WilliamsNashville$213K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
- Nicole DelliseNashville$67K
- Lesley BallanceNashville$63K
- Jeffrey WoodsNashville$38K
- Courtney HavillNashville$35K
- Collette UtleyNashville$28K
- Stacy BrownMt Juliet$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.